Novo Nordisk Pharmaceuticals Pty Limited is a foreign-owned private company, deriving revenue from the marketing and distribution of pharmaceutical products, and the operation of a Clinical Trial Development Unit. The Company employs approximately 115 people, operates in Australia, and is administered from its head office in Baulkham Hills, New South Wales.
 The Company is a wholly owned subsidiary of Denmark-based pharmaceutical company, Novo Nordisk A/S.

Novo Nordisk Pharmaceuticals research and develop a range of pharmaceutical products designed to assist in a wide range of health issues. 

The company offers products and services in five therapeutic areas:

  • Diabetes Care
  • Haemophilia & Bleeding Disorders
  • Obesity and Weight Management
  • Hormone Replacement Therapy
  • Growth Hormone Therapy

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

This Company Has Operations in the Following Industries:

Pharmaceuticals Wholesaling in Australia
Scientific Research Services in Australia

Table of Contents

Company Details
Key Personnel
Growth & Ratios
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.